ストックスクリーナーアプリを入手
266.57
3.90%
10.01
アフターアワーズ：
266.57
前日終値:
$256.56
開ける：
$256.56
24時間の取引高:
1.18M
Relative Volume:
2.15
時価総額：
$18.70B
収益：
$1.98B
当期純損益:
$420.90M
株価収益率:
155.89
EPS:
1.71
ネットキャッシュフロー:
$218.20M
1週間 パフォーマンス:
-1.03%
1か月 パフォーマンス:
-0.00%
6か月 パフォーマンス:
+33.75%
1年 パフォーマンス:
+28.18%
1日の値動き範囲:
$256.56
$270.70
1週間の範囲:
$254.79
$271.18
52週間の値動き範囲:
$160.19
$279.77
Insulet Corporation Stock (PODD) Company Profile
PODD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PODD
Insulet Corporation
|
266.57 | 18.70B | 1.98B | 420.90M | 218.20M | 5.84 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-06 | 開始されました | Bernstein | Outperform |
| 2024-05-30 | 開始されました | Redburn Atlantic | Buy |
| 2024-05-07 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-21 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2023-12-04 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-02 | アップグレード | Jefferies | Hold → Buy |
| 2023-08-21 | アップグレード | Citigroup | Neutral → Buy |
| 2023-08-21 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-01-26 | 開始されました | Wolfe Research | Peer Perform |
| 2022-11-04 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-07-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-31 | アップグレード | Oppenheimer | Perform → Outperform |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-01 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-03-19 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-07-28 | 開始されました | Wells Fargo | Overweight |
| 2020-04-24 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-03 | 開始されました | BofA/Merrill | Neutral |
| 2020-03-31 | ダウングレード | Berenberg | Buy → Hold |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-12-10 | 開始されました | CFRA | Sell |
| 2019-10-23 | 開始されました | Stifel | Hold |
| 2019-10-18 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2019-10-14 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-10-04 | ダウングレード | UBS | Buy → Neutral |
| 2019-10-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-08-06 | アップグレード | JP Morgan | Neutral → Overweight |
| 2019-06-10 | ダウングレード | Northland Capital | Outperform → Market Perform |
| 2019-05-06 | アップグレード | BTIG Research | Neutral → Buy |
| 2018-04-20 | 開始されました | Berenberg | Buy |
| 2018-02-22 | 繰り返されました | Barclays | Overweight |
| 2018-01-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-11-03 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2017-09-15 | 開始されました | Barclays | Overweight |
すべてを表示
Insulet Corporation (PODD) 最新ニュース
The Most Significant Trade Secrets Cases Of 2024 - Law360
Executive VP Of Insulet Sold 26% Of Their Shares - Simply Wall St
Insulet Corp. stock outperforms competitors on strong trading day - MarketWatch
Insulet Co. (NASDAQ:PODD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Here's Why Insulet (NASDAQ:PODD) Can Manage Its Debt Responsibly - Simply Wall St
Insulet corp EVP Benjamin Eric sells $1.17 million in shares By Investing.com - Investing.com Australia
Insulet corp EVP Benjamin Eric sells $1.17 million in shares - Investing.com India
Here's How Much $1000 Invested In Insulet 15 Years Ago Would Be Worth Today - Benzinga
Stocks Fall As Breadth Remains Weak; Fortinet, Insulet, Embraer In FocusVideoIBD - Investor's Business Daily
Virtu Financial LLC Makes New $616,000 Investment in Insulet Co. (NASDAQ:PODD) - MarketBeat
Toronto Dominion Bank Buys 3,117 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Stake Raised by Geode Capital Management LLC - MarketBeat
Insulet's SWOT analysis: tubeless pump maker's stock faces competition - Investing.com
Why Insulet (PODD) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Insulet Co. (NASDAQ:PODD) Shares Sold by Y Intercept Hong Kong Ltd - MarketBeat
Orion Portfolio Solutions LLC Purchases 3,623 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet stock soars to 52-week high, reaching $279.42 - Investing.com India
RMD or PODD: Which Is the Better Value Stock Right Now? - Yahoo Finance
Insulet stock soars to 52-week high, reaching $279.42 By Investing.com - Investing.com UK
National Bank of Canada FI Decreases Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet corp executive sells $252,192 in common stock By Investing.com - Investing.com Nigeria
Insulet corp executive sells $252,192 in common stock - Investing.com India
Should You Continue to Retain Insulet Stock in Your Portfolio Now? - MSN
Tandem Diabetes (TNDM) and Insulet (PODD) Volatility Attributed to Channel-Check Firm - StreetInsider.com
Google Takes Quantum Leap But Growth Weak Again; AppLovin, Insulet In Focus TooVideoIBD - Investor's Business Daily
Quantinno Capital Management LP Acquires 7,270 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Bought by Nomura Asset Management Co. Ltd. - MarketBeat
3,459 Shares in Insulet Co. (NASDAQ:PODD) Purchased by SGL Investment Advisors Inc. - MarketBeat
Insulet Co. (NASDAQ:PODD) Position Trimmed by Groupama Asset Managment - MarketBeat
XTX Topco Ltd Acquires Shares of 6,351 Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet successfully defends its Intellectual property against EOFlow - Medical Buyer
Insulet wins $452M in lawsuit against rivals over medical device trade secrets - Cardiovascular Business
Jury awards Insulet $452M against Eoflow in trade secrets case - BioWorld Online
Insulet wins $452M in trade secret case By Investing.com - Investing.com Australia
Insulet Wins $452M Trade Secrets Verdict Against EOFlow - USA Herald
Readystate Asset Management LP Trims Holdings in Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet wins $452 mln US verdict against EOFlow in insulin pump secrets case - Reuters
Insulet Wins $452M Jury Verdict in Trade Secrets Battle with EOFlow - USA Herald
Insulet awarded $452M in EOFlow patent fight - MedTech Dive
Insulet Wins $452 Million in Insulin Pump Trade Secrets Trial - Bloomberg Law
Insulet's Legal Win Against EOFlow Over Trade Secret Theft - Finimize
BREAKING: Insulet Corp. Wins $452M In Trade Secret Theft Trial - Law360
Insulet Wins $452 Million Trade Secret Victory Against EOFlow - MPO-mag
Insulet Corporation (PODD) Secures Major Legal Victory with $452 Million Jury Award - GuruFocus.com
Insulet wins $452M in trade secret case - Investing.com India
Insulet Successfully Defends its Intellectual Property Against EOFlow Co. in U.S. District Court - Business Wire
Insulet Co. (NASDAQ:PODD) Shares Sold by Parkman Healthcare Partners LLC - MarketBeat
Insulet Co. (NASDAQ:PODD) Shares Sold by The Manufacturers Life Insurance Company - MarketBeat
Beacon Investment Advisory Services Inc. Has $37.84 Million Stock Position in Insulet Co. (NASDAQ:PODD) - MarketBeat
70,213 Shares in Insulet Co. (NASDAQ:PODD) Acquired by Caisse DE Depot ET Placement DU Quebec - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Buys 5,031 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
Insulet Corporation (PODD) 財務データ
収益
当期純利益
現金流量
EPS
1.54%
大文字化:
|
ボリューム (24 時間):